Literature DB >> 34550427

2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS.

Andrea Paccagnella1, Andrea Farolfi2, Beatrice Casadei3,4, Valentina Garibotto5, Pierluigi Zinzani3,4, Stefano Fanti2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34550427     DOI: 10.1007/s00259-021-05562-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study.

Authors:  Michael Crump; Sattva S Neelapu; Umar Farooq; Eric Van Den Neste; John Kuruvilla; Jason Westin; Brian K Link; Annette Hay; James R Cerhan; Liting Zhu; Sami Boussetta; Lei Feng; Matthew J Maurer; Lynn Navale; Jeff Wiezorek; William Y Go; Christian Gisselbrecht
Journal:  Blood       Date:  2017-08-03       Impact factor: 22.113

2.  Neurological toxicities associated with chimeric antigen receptor T-cell therapy.

Authors:  Daniel B Rubin; Husain H Danish; Ali Basil Ali; Karen Li; Sarah LaRose; Andrew D Monk; David J Cote; Lauren Spendley; Angela H Kim; Matthew S Robertson; Matthew Torre; Timothy R Smith; Saef Izzy; Caron A Jacobson; Jong Woo Lee; Henrikas Vaitkevicius
Journal:  Brain       Date:  2019-05-01       Impact factor: 13.501

3.  Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Authors:  Sattva S Neelapu; Frederick L Locke; Nancy L Bartlett; Lazaros J Lekakis; David B Miklos; Caron A Jacobson; Ira Braunschweig; Olalekan O Oluwole; Tanya Siddiqi; Yi Lin; John M Timmerman; Patrick J Stiff; Jonathan W Friedberg; Ian W Flinn; Andre Goy; Brian T Hill; Mitchell R Smith; Abhinav Deol; Umar Farooq; Peter McSweeney; Javier Munoz; Irit Avivi; Januario E Castro; Jason R Westin; Julio C Chavez; Armin Ghobadi; Krishna V Komanduri; Ronald Levy; Eric D Jacobsen; Thomas E Witzig; Patrick Reagan; Adrian Bot; John Rossi; Lynn Navale; Yizhou Jiang; Jeff Aycock; Meg Elias; David Chang; Jeff Wiezorek; William Y Go
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

4.  Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomas.

Authors:  Nirav N Shah; Sarah J Nagle; Drew A Torigian; Michael D Farwell; Wei-Ting Hwang; Noelle Frey; Sunita D Nasta; Daniel Landsburg; Anthony Mato; Carl H June; Stephen J Schuster; David L Porter; Jakub Svoboda
Journal:  Cytotherapy       Date:  2018-10-29       Impact factor: 5.414

  4 in total
  1 in total

Review 1.  Metabolic Imaging in B-Cell Lymphomas during CAR-T Cell Therapy.

Authors:  Flavia Linguanti; Elisabetta Maria Abenavoli; Valentina Berti; Egesta Lopci
Journal:  Cancers (Basel)       Date:  2022-09-27       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.